Evaluating lung cancer screening disparities in an integrated healthcare system: barriers and opportunities
RationaleThe national average rate of lung cancer screening (LCS) has remained low at roughly 6%, with California’s rate among the lowest at 1% compared to all fifty states.MethodsWe enrolled Kaiser Permanente Northern California (KPNC) patients eligible for LCS per the USPSTF guidelines published i...
Saved in:
| Main Authors: | Carmen Javier, Sheng-Fang Jiang, Jenna Philippe, Isabel Arana, Jeffrey B. Velotta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1601458/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Performance of lung cancer screening with low‐dose CT in Gejiu, Yunnan: A population‐based, screening cohort study
by: Meng‐Na Wei, et al.
Published: (2020-05-01) -
Lung cancer screening in Finland: a prospective randomized trial
by: Viktor Wichmann, et al.
Published: (2025-06-01) -
Assessing factors influencing participation in LDCT lung cancer screening among high-risk urban populations in Nanjing, China
by: Meijing Liu, et al.
Published: (2025-07-01) -
Cost-effectiveness of low-dose CT screening for non-smokers with a first-degree relative history of lung cancer
by: Yin Liu, et al.
Published: (2025-05-01) -
Benefits, harms, and cost-effectiveness of risk model-based and risk factor-based low-dose computed tomography screening strategies for lung cancer: a systematic review
by: Yin Liu, et al.
Published: (2024-12-01)